News Banner

tapros santen Society

Just fill in the form below, click submit, you will get the price list, and we will contact you within one working day. Please also feel free to contact us via email or phone. (* is required).

  • Santen Announces Approval of TAPROS

    2015-8-25 · Santen is the market leader in Japan for prescription ophthalmic pharmaceuticals and sells products in over 50 countries. As a leading company in the field of ophthalmology, Santen aims to contribute to society by supplying valuable products and services to satisfy unmet medical needs. For more details, please see Santen’s website (www.santen.com

    Get Price
  • 2001-Current | History | Overview | About Us | Santen ...

    Santen launches Tapros, a treatment for glaucoma and ocular hypertension Tapros is the fruit of Santen's first global development project spanning Japan, the U.S., Europe and Asia. The product is currently being sold in Japan as well as countries in Europe and Asia, and is gaining attention in ophthalmic markets in Japan and around the world as ...

    Get Price
  • Feature Contributions to the World’s - Santen

    2017-3-31 · 18 Santen Pharmaceutical Co., Ltd. Annual Report 2017 27 % Contributions to the World’s Glaucoma Patients ... Japan Glaucoma Society High Hopes for Santen to Continue Developing Products Attuned to the Needs of Glaucoma Patients ... such as Tapros, Cosopt, ...

    Get Price
  • Top Message - Santen

    2017-1-18 · 10 Santen Pharmaceutical Co., Ltd. Annual Report 2016 Top Message Overview of the Fiscal Year Ended March 31, 2016 ... Tapros (tafluprost), a treatment of glaucoma and ocular ... around the world and contributing to society. We kindly ask for the continued support of all of our stakeholders.

    Get Price
  • Santen Report 2020

    2020-9-16 · 44 Building an Inclusive Society 46 Diversity and Inclusion Corporate Governance ... Tapros (treatment for glaucoma and ocular hypertension) 2013 Alesion (anti-allergy ophthalmic) 2010 ... Santen employees worldwide respect diversity (page 46) and turn it into an advantage to create greater outcomes. Pharmaceutical companies

    Get Price
  • Therapeutic Areas | Santen Pharmaceutical Asia Pte. Ltd.

    At Santen Asia, We Believe That By Improving Patients' Well-Being, We Also Contribute To Their Loved Ones, And Consequently To Society. THERAPEUTIC AREAS. Dry Eye. Dry Eye disease is characterized by injuries to the eye surface associated with an uneven supply of tears, a lack of tear volume, or a collapse of the qualitative balance of tears.

    Get Price
  • Ocular surface cytotoxicity and safety evaluation of ...

    2014-2-13 · The %CVS 40/80 of Tapros (Santen, Osaka, Japan) was 99, indicating that the product showed almost no cytotoxic effect, and suggesting that of the five PG analog eyedrops tested, Tapros would be least cytotoxic to ocular surface cells.

    Get Price
  • The Protein Society : External Home Page

    2019-6-17 · 6.12 Tapros (tafluprost) - Santen 6.12.1 Tapros: Sales Forecast 2019-2029 6.13 Zioptan (tafluprost) - Akorn ... American Society of Retina Specialists (ASRS) CDSCO (India) European Union European Commission Health Canada (Canada) Institute of ...

    Get Price
  • Santen’s preservative-free glaucoma drug approved

    2013-1-24 · Santen Pharmaceutical Co., Ltd. announced that Japan's Ministry of Health, Labour and Welfare has granted manufacturing and marketing clearance to Tapros Mini Ophthalmic Solution 0.0015%  (taflup

    Get Price
  • Ocular surface cytotoxicity and safety evaluation of ...

    2014-2-13 · The %CVS 40/80 of Tapros (Santen, Osaka, Japan) was 99, indicating that the product showed almost no cytotoxic effect, and suggesting that of the five PG analog eyedrops tested, Tapros would be least cytotoxic to ocular surface cells.

    Get Price
  • Tafluprost for the Reduction of Interocular Pressure

    2011-6-12 · Finland), both in 0,0015% (15 μg/ml) concentration. 15 In Japan it is formulated with BAK- Tapros® (Santen Pharmaceutical Co. Ltd. Osaka, Japan). Mechanism of Action of Tafluprost Tafluprost has demonstrated affinity for the prostanoid FP receptor that seems to be greater than for other prostaglandins available.

    Get Price
  • A 6-month study comparing efficacy, safety, and ...

    2014-12-2 · Tafluprost ophthalmic solution 0.0015% (Taflotan™, Saflutan™, Tapros™, Santen, Osaka, Japan) was the first prostaglandin analog (PGA) that became available in a PF formulation. The IOP-lowering efficacy of this PF formulation is comparable to that of latanoprost [20–22]. PGA/timolol FCs are frequently used in glaucoma management.

    Get Price
  • Tafluprost Ophthalmic Solution 0.0015 %: A Review

    2016-5-25 · Santen Pharmaceutical Co Ltd. Tapros ® (tafluprost) ophthalmic solution 0.0015 %: Japanese prescribing information. 2015. 27. Kuwayama Y, Komemushi S. Intraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double-blind, multicenter, phase III study [in Japanese].

    Get Price
  • Ube and Santen Announce License and

    2011-10-14 · By obtaining global development manufacturing commercializing rights for DE-117, Santen now has a global candidate compound to follow 'Tapros' (generic name: Tafluprost), a prostaglandin (FP agonist) which Santen has been marketing since 2008 for …

    Get Price
  • Efficacy and safety of tafluprost in normal-tension ...

    2011-8-27 · After baseline IOP had been measured five times or more within a period of 3 months, tafluprost (Tapros, Santen, Osaka, Japan) was administered to the eye with the lower MD (the study eye) once daily (1 drop each time) for 12 weeks. The IOP was measured at 2, 4, 8 and 12 weeks after the start of tafluprost instillation.

    Get Price
  • Pharmacokinetics, Efficacy, and Safety of the

    2015-9-21 · Plasma concentrations of tafluprost acid and timolol were compared after single (Day 1) and repeated (Day 8) instillations of once-daily tafluprost 0.0015 %-timolol 0.5 % preservative-free (PF) fixed-dose combination (FDC), once-daily PF tafluprost 0.0015 %, and twice-daily PF timolol 0.5 %. Fifteen healthy volunteers were randomized to this double-masked, single-center, three-period cross ...

    Get Price
  • Pharma Leader Series: Top 25 Ophthalmic Drug

    2014-3-3 · Assess product portfolios, other activities and revenue predictions to 2024:• Santen• Senju• ValeantYou find sales prospects for brands such as Hyalein, Tapros/Taflotan, Cravit, and Diquas ...

    Get Price
  • FDA Approves ZIOPTAN™ (tafluprost ophthalmic

    2012-2-13 · ZIOPTAN is a New and Effective Prostaglandin Analog Option for Lowering Elevated Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first …

    Get Price
  • Ube and Santen Announce License and Collaboration ...

    2011-10-14 · By obtaining global development manufacturing commercializing rights for DE-117, Santen now has a global candidate compound to follow 'Tapros' (generic name: Tafluprost), a prostaglandin (FP agonist) which Santen has been marketing since 2008 for …

    Get Price
  • Japanese drugmaker Santen forays into India - Nikkei

    2014-12-2 · Tafluprost ophthalmic solution 0.0015% (Taflotan™, Saflutan™, Tapros™, Santen, Osaka, Japan) was the first prostaglandin analog (PGA) that became available in a PF formulation. The IOP-lowering efficacy of this PF formulation is comparable to that of latanoprost [20–22]. PGA/timolol FCs are frequently used in glaucoma management.

    Get Price
  • A 6-Month Study Comparing Efficacy, Safety, and ...

    2014-2-13 · In vitro cytotoxicity of tafluprost, which is the most recently developed anti-glaucoma prostaglandin (PG) analog, in ocular surface cells is addressed in comparison with other PG analogs. Irrespective of cell lines and models, the cytotoxicity of anti-glaucoma PG eyedrops was primarily related to the concentration of benzalkonium chloride (BAK) contained in the eyedrops as a preservative.

    Get Price
  • Ocular Surface Cytotoxicity and Safety Evaluation of ...

    2020-1-8 · 他氟前列素滴眼液 Tafluprost Eye Drops/Tapros(泰普罗斯) 2.5ml:37.5μg(0.0015%) 滴眼剂 Santen Pharmaceutical Co.,Ltd. 国内上市的原研药品 原研进口 他氟前列素滴眼液 Tafluprost Eye Drops/Tapros 0.0015%(0.3ml) 滴眼剂 参天製薬株式会社 未进口 ...

    Get Price
  • All Eyes On: Diversity and inclusion | Santen

    2014-8-4 · 7.12 Tapros (tafluprost, Santen) 7.12.1 Tapros/Taflotan: Sales Forecast 2014-2024 7.13 Zioptan (tafluprost, Akorn) ... Macular Society, Andover, Hampshire, UK 12.1.1 The Work of the Macular Society

    Get Price
  • Ophthalmic Drugs Market Forecast 2014-2024:

    2021-7-8 · The formation of the Asia Cornea Society (ACS) is spurred by a common vision amongst corneal subspecialists and researchers throughout Asia to foster the exchange of knowledge and information on clinical, educational and research aspects of the corneal subspecialty with particular focus and relevance to Asian corneal diseases.

    Get Price
  • About ACS - Asia Cornea Society

    In order to elucidate the cost-effectiveness of various ophthalmic solutions used for the treatment of glaucoma, we compared the daily price for solutions resulting in a 1-mmHg reduction in intraocular pressure (IOP) in glaucoma

    Get Price
  • Preperimetric Glaucoma Prospective Observational

    2017-12-13 · Tafluprost ophthalmic solution 0.0015% (TAPROS ®; Santen Pharmaceutical, Osaka, Japan) is a selective prostaglandin F receptor agonist, and topical administration of tafluprost reduces IOP in glaucoma patients.

    Get Price
  • Tafluprost Ophthalmic Solution 0.0015 %: A Review

    2016-5-25 · Santen Pharmaceutical Co Ltd. Tapros ® (tafluprost) ophthalmic solution 0.0015 %: Japanese prescribing information. 2015. 27. Kuwayama Y, Komemushi S. Intraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double-blind, multicenter, phase III study [in Japanese].

    Get Price
  • Switching Study of Tafluprost/Timolol Fixed

    2019-11-6 · Purpose: Fixed-combination medication to treat glaucoma can reduce intraocular pressure (IOP) without negative effects of concomitant medication. Tafluprost/timolol fixed-combination ophthalmic solution (TTFC) has been reported to show similar effectiveness in lowering IOP, compared with concomitant use of its component drugs, tafluprost and timolol.

    Get Price
  • Santen Going on Offensive in Growth Fields in ...

    2012-10-24 · Santen Pharmaceutical, the top player in the ophthalmology field, is going on the offensive in the market for glaucoma and retinal disease treatments. Buoyed by sharp growth in its new portfolio, including its proprietary Tapros Ophthalmic Solution (tafluprost), the company…

    Get Price
  • [Optimization of benzalkonium chloride

    2010-6-1 · Optimization of benzalkonium chloride (alkyl dimethylbenzylammonium chloride: BAK) concentration as preservative in 0.0015% tafluprost ophthalmic solution (Tapros 0.0015% ophthalmic solution), an anti-glaucoma medicine, was examined from the points of ocular surface safety and preservative efficacy.

    Get Price
  • Efficacy and Safety of Switching from Tafluprost to a ...

    2014-12-2 · Tafluprost ophthalmic solution 0.0015% (Taflotan™, Saflutan™, Tapros™, Santen, Osaka, Japan) was the first prostaglandin analog (PGA) that became available in a PF formulation. The IOP-lowering efficacy of this PF formulation is comparable to that of latanoprost [20–22]. PGA/timolol FCs are frequently used in glaucoma management.

    Get Price
  • A 6-Month Study Comparing Efficacy, Safety, and ...

    2014-8-4 · 7.12 Tapros (tafluprost, Santen) 7.12.1 Tapros/Taflotan: Sales Forecast 2014-2024 7.13 Zioptan (tafluprost, Akorn) ... Macular Society, Andover, Hampshire, UK 12.1.1 The Work of the Macular Society

    Get Price
  • Ophthalmic Drugs Market Forecast 2014-2024:

    2012-2-13 · ZIOPTAN is a New and Effective Prostaglandin Analog Option for Lowering Elevated Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first …

    Get Price
  • FDA Approves ZIOPTAN™ (tafluprost ophthalmic

    Santen’s Values and Mission Statement *1 Santen’s original interpretation of a passage from chapter 22 of Zhongyong (The Doctrine of the Mean) by Confucius, meaning “exploring the secrets and mechanisms of nature in order to contribute to people’s health.” By focusing on ophthalmology, Santen …

    Get Price
  • Tafluprost Ophthalmic Solution 0.0015 %: A Review in ...

    2016-5-25 · Santen Pharmaceutical Co Ltd. Tapros ® (tafluprost) ophthalmic solution 0.0015 %: Japanese prescribing information. 2015. 27. Kuwayama Y, Komemushi S. Intraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double-blind, multicenter, phase III study [in Japanese].

    Get Price
  • Santen Going on Offensive in Growth Fields in ...

    2012-10-24 · Santen Pharmaceutical, the top player in the ophthalmology field, is going on the offensive in the market for glaucoma and retinal disease treatments. Buoyed by sharp growth in its new portfolio, including its proprietary Tapros Ophthalmic Solution (tafluprost), the company…

    Get Price
  • The Sane Society - Wikiquote

    2021-5-31 · 中国行政管理学会

    Get Price
  • Santen Group Corporate Profile - pharmacy.pusan.ac.kr

    Santen’s Values and Mission Statement *1 Santen’s original interpretation of a passage from chapter 22 of Zhongyong (The Doctrine of the Mean) by Confucius, meaning “exploring the secrets and mechanisms of nature in order to contribute to people’s health.” By focusing on ophthalmology, Santen …

    Get Price
  • IOM3 | Iron & Steel Society

    The Iron & Steel Society at 150 Years. View the Iron & Steel Society's collection of web pages on the IOM3 archive site showing a legacy of 150 years of the iron & steel industry, with a wide array of presentations, videos, photographs and commentary about the past, the present, and indeed potential future opportunities. View now

    Get Price
  • Amazon.com: Risk Society: Towards a New Modernity ...

    Society of Automotive Engineers of China Jul 09, 2021 Friday English | Chinese Promote scientific and technical progress in the automotive industry,Train automotive talents,Push forward technical exchanges between domestic and international automotive Home ...

    Get Price
  • Society - Global Times

    Beck explains that society fights the `devil of hunger′ with the `Beelzebub of multiplying risks′. He also claims that, in industrial society, the driving force is `I am hungry′ whereas in risk society it is `I am afraid′. Such gripping conceptualisations are the mark of a distinguished essaysist, as Beck is.

    Get Price